To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Jasper Therapeutics adds new VP to team
Jasper Therapeutics, a biotech company focused on hematopoietic cell transplant therapies, has named Dr. Kevin N. Heller as executive vice president of research and development.
